Top Ranked Momentum Stocks to Buy for December 3rd

IRWD CHRS

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 3rd:

Coherus BioSciences, Inc. (CHRS - Free Report) : This commercial-stage biotherapeutics company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 52.8% over the last 60 days.

Coherus BioSciences’ shares gained 7.6% over the last one month above the S&P 500’s increase 1.2%. The company possesses a Momentum Score of A.

Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) : This commercial biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Ironwood Pharmaceuticals’ shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.

Otonomy, Inc. : This biopharmaceutical company that focuses on development of therapeutics for neurotology has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.

Otonomy’s shares gained 5.9% over the last one month. The company possesses a Momentum Score of A.

Unique Fabricating, Inc. : This company that engineers and manufactures multi-material foam, rubber, and plastic components has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.

Unique Fabricating’s shares gained 44.2% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>